Napa, California—May 23, 2014—Top orthopedists joined medical malpractice insurance executives today to discuss innovative solutions to emerging challenges facing their specialty at the inaugural meeting of the Orthopedic Advisory Board. The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, sponsored the meeting.
Ralph Gambardella, MD, chairman, president, Kerlan-Jobe Orthopaedic Clinic in Los Angeles, California, and Douglas Lundy, MD, FACS, co-president, Resurgens Orthopaedics in Atlanta, Georgia, were guest speakers at the event, which was attended by advisory board members from throughout the nation.
In his presentation, “Regenerative Medicine in Orthopaedics: New Challenges,” Dr. Gambardella, a renowned sports medicine specialist, focused on the issue of using stem cells to repair or rebuild bones. Dr. Lundy, a specialist in orthopedic trauma surgery, discussed the challenge of measuring physician quality in “Raising the Bar: Use of a Physician Scorecard in Specialty Practice.”
“Regenerative medicine holds the promise of regenerating damaged tissues and organs in the body by replacing damaged tissue and/or by stimulating the body’s own repair mechanisms to heal previously irreparable tissues or organs,” said Dr. Gambardella. “It also includes the possibility of growing tissues and organs in the laboratory and safely implanting them when the body cannot heal itself, potentially solving the problems of the shortage of organs for donation and of organ transplant rejection.”
Today, thousands of orthopedists are using stem cells to repair or rebuild bone within focal cavities, Dr. Gambardella said. The popularity of this procedure soared in 2012, with 100,000 procedures performed that year alone, compared to a million procedures over the previous 15 years. But the challenges orthopedists face include how the government regulates the process and how to reduce risks inherent in off-label use of a medical product.
Another challenge facing orthopedists today is the establishment of quality measurements, which help reduce risk and increase patient safety, according to Dr. Lundy, who was instrumental in developing a nationally recognized physician scorecard at Resurgens. A successful scorecard, according to Dr. Lundy, should include:
Dr. Lundy discusses more on this topic in the video, “Boost Best Practices with a Physician Scorecard.”
“Innovative treatments in orthopedic medicine and measuring physician quality are two of the most pressing issues facing this specialty today,” said David B. Troxel, MD, medical director, The Doctors Company. “Solutions to these issues can best be generated at forums like the Orthopedic Advisory Board, where key leaders practicing on the front lines of medicine meet to share their experiences and insights.”
About The Doctors Company
Founded by doctors for doctors in 1976, The Doctors Company is relentlessly committed to advancing, protecting, and rewarding the practice of good medicine. The Doctors Company is the nation’s largest physician-owned medical malpractice insurer, with 75,000 members and $4 billion in assets, and is rated A by A.M. Best Company and Fitch Ratings.
Follow The Doctors Company on Twitter at @doctorscompany for industry trends, subscribe to its YouTube site to hear from industry experts, connect with The Doctors Company on LinkedIn to engage with company leaders, and find information on its key milestones and achievements on Facebook.